Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind LtdfiledCriticalSun Pharmaceutical Ind Ltd
Priority to ARP030104847priorityCriticalpatent/AR042822A1/en
Publication of AR042822A1publicationCriticalpatent/AR042822A1/en
Sistema de administración controlada de fármacos de retención gástrica que comprende: (a) un núcleo de liberación controlada que comprende un fármaco, un polímero altamente expansible y un agente generador de gas, en donde dicho núcleo es capaz de expandirse y lograr flotación rápidamente mientras mantiene su integridad física en fluidos gastrointestinales pro períodos prolongados, y (b) una composición de recubrimiento que se libera rápidamente, que comprende el mismo fármaco que el núcleo y excipientes farmacéuticamente aceptables, en donde la composición de recubrimiento rodea el núcleo y excipientes farmacéuticamente aceptables, en donde la composición de recubrimiento rodea el núcleo de modo tal que el sistema provee una liberación bifásica del fármaco baclofeno, entre otros, en fluidos gastrointestinales.Controlled gastric retention drug delivery system comprising: (a) a controlled release core comprising a drug, a highly expandable polymer and a gas generating agent, wherein said core is capable of rapidly expanding and float while maintaining its physical integrity in gastrointestinal fluids for prolonged periods, and (b) a rapidly releasing coating composition, comprising the same drug as the core and pharmaceutically acceptable excipients, wherein the coating composition surrounds the core and pharmaceutically acceptable excipients, wherein the coating composition surrounds the core such that the system provides a biphasic release of the drug baclofen, among others, in gastrointestinal fluids.
ARP0301048472003-12-292003-12-29
CONTROLLED ADMINISTRATION SYSTEM OF GASTRIC RETAINING PHARMACES WITH ENTERIC COVERAGE
AR042822A1
(en)
USE OF A TYPE C METACRYLIC ACID COPOLYMER ACCORDING TO THE US NATIONAL FORMULARY USP / NF PHARMACOPEA, AS A DEGREGATION AGENT AND THE MANUFACTURING PROCEDURE OF A TABLET WITH SUCH COPOLYMER
Pharmaceutical implant for controllably releasing a drug, method for controllably releasing a drug in an individual, and method for preparing the implant
Oral dissolving film composition comprising a cosmetic or pharmaceutical active agent, and a polyvinyl alcohol-polyethylene glycol graft copolymer (application divisional 1825-04).
A SOLID PHARMACEUTICAL COMPOSITION IN THE FORM OF A TABLET THAT INCLUDES A BENZOFURAN DERIVATIVE WITH ANTIARRHYTHMIC ACTIVITY ADAPTED FOR ORAL ADMINISTRATION
Solid dosage formulation, controlled release tablet, method of manufacturing a controlled release medication, pharmaceutical composition and use of a composition